| Drug Name: | Capecitabine (154361-50-9) |
|---|---|
| PubChem ID: | 60953 |
| SMILES: | CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O |
| InchiKey: | GAGWJHPBXLXJQN-UORFTKCHSA-N |
| Therapeutic Category: | Antimetabolites, Antineoplastic Agents, Noxae |
| Molecular Weight (dalton) | : | 359.354 |
| LogP | : | 0.7602 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 8 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 122.91 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Folic Acid (59-30-3) | Diarrhoea | Synergistic | concurrent use of folic acid enhanced capecitabine toxicity | Lethal toxicity of capecitabine due to abusive folic acid prescription? |
| Folic Acid (59-30-3) | Hand-And-Foot Syndrome | Synergistic | concurrent use of folic acid enhanced capecitabine toxicity | Lethal toxicity of capecitabine due to abusive folic acid prescription? |
| Folic Acid (59-30-3) | Vomiting | Synergistic | concurrent use of folic acid enhanced capecitabine toxicity | Lethal toxicity of capecitabine due to abusive folic acid prescription? |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category